Explore our industrial-grade active pharmaceutical ingredients, custom synthesis products, and high-purity bulk chemical solutions.
In-depth structural characterization, commercial utility, and supply chain verification for Growth Hormone Releasing Peptide-2 (Pralmorelin).
GHRP-2 (Pralmorelin Acetate) is a synthetic hexapeptide with the chemical sequence D-Ala-D-2Nal-Ala-Trp-D-Phe-Lys-NH2 (CAS Registry Number: 158861-67-7). Functioning as a potent ghrelin receptor agonist (GHS-R1a), GHRP-2 selectively stimulates the release of endogenous growth hormone (GH) from the anterior pituitary gland without altering baseline cortisol or prolactin concentrations under physiological dosing parameters.
Information Gain Key Takeaway: When commercial entities look to Buy GHRP-2 10mg, quality verification must extend beyond basic HPLC assay. Purity must be validated against isomeric D-amino acid side-chain variants and cleavage by-products caused during solid-phase peptide synthesis (SPPS).
The standard enterprise packaging specification of 10mg per vial represents an optimal balance between peptide stability, reconstitutive concentration control, and shipping payload efficiency. Lyophilized (freeze-dried) GHRP-2 in 10mg unit dosage form provides exceptional long-term stability when stored at -20°C, rendering it ideal for commercial distribution, B2B re-packaging, and clinical trial drug supply chains.
Pharmaceutical manufacturers and biotechnology procurement officers require strict batch-to-batch consistency, low residual trifluoroacetic acid (TFA) salts (<1.0%), and endotoxin limits compliant with international cGMP standards (<0.05 EU/mg).
Our standardized analytical requirements ensure optimal bioactivity, chemical purity, and regulatory compliance for international pharmaceutical procurement.
| Analytical Parameter | Testing Methodology | Acceptance Criteria (Commercial Grade) | c-GMP Benchmark (Pharmaceutical Grade) |
|---|---|---|---|
| Chemical Purity (HPLC) | RP-HPLC (C18 Column, Gradient Elution) | ≥ 98.0% Peak Area | ≥ 99.0% Peak Area |
| Molecular Mass Verification | ESI-MS / MALDI-TOF Mass Spectrometry | 817.9 ± 0.5 Da (Exact Mass match) | Conforms to Theoretical Monoisotopic Mass |
| Endotoxin Level | Chromogenic LAL Assays (USP <85>) | < 0.1 EU/mg | < 0.05 EU/mg (Sterile Injectable Grade) |
| Peptide Content (N-Analysis) | Elemental Nitrogen / AAA | ≥ 80.0% Net Peptide Content | ≥ 85.0% Net Peptide Content |
| Moisture Content (Karl Fischer) | Coulometric Titration (USP <921>) | ≤ 5.0% Residual Water | ≤ 3.0% Lyophilization Standard |
| Residual Solvent Profile | Headspace Gas Chromatography (GC-HS) | Meets ICH Q3C Guidelines (TFA < 1%) | Class 1 & 2 Solvents Below Detection Limits |
| Bioburden Testing | Membrane Filtration (USP <61>) | < 10 CFU/vial | Sterile / Zero Colony Growth |
Connecting global biopharma with high-purity peptide APIs, custom formulation setups, and complete supply chain protection.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
View Details
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Advanced synthesis route development, analytical validation protocols, and custom peptide engineering tailored for scalable clinical production.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Global Accreditation & Partner Network
Mitigating supply chain risks, ensuring international regulatory compliance, and establishing OEM standard operating procedures.
Enterprise buyers evaluating GHRP-2 10mg companies must assess scale capabilities. Scalable automated Solid Phase Peptide Synthesis (SPPS) platforms allow for production batches ranging from 100g to multi-kilogram API quantities.
OEM solutions include customized lyophilization vial sizes (2ml, 5ml, 10ml tubular glass vials), tamper-evident flip-off caps, custom labeling, and secondary sterile packaging under ISO 5 cleanroom conditions.
Peptides are thermosensitive macromolecules prone to aggregation and hydrolytic degradation under elevated temperatures. Our bulk export operations utilize validated cold-chain shipping protocols (-20°C dry-ice containers or 2–8°C insulated phase-change packs).
Every shipment includes real-time USB/Bluetooth temperature data loggers ensuring continuous monitoring from facility dispatch through customs clearance.
Regulatory approval requires exhaustive analytical verification. We supply full regulatory filing support, including Drug Master Files (DMF), Certificates of Analysis (CoA), Materials Safety Data Sheets (MSDS/SDS), and ICH stability testing reports (accelerated and long-term).
This complete documentation suite streamlines authorization for commercial formulation and clinical stage trial use worldwide.
Advancing synthetic efficiency, green chemistry coupling, and next-generation delivery technologies for GHRP-2 and growth factor secretagogues.
Traditional peptide synthesis relies heavily on hazardous solvents like DMF and NMP. Modern process chemistry is rapidly transitioning toward Green SPPS using eco-friendly solvents (such as Gamma-Valerolactone and 2-MeTHF) and advanced coupling reagents (e.g., Oxyma Pure / DIC systems).
By integrating automated continuous flow microwave reactors, synthesis cycle times for GHRP-2 hexapeptide sequences are reduced by up to 70%, while simultaneously decreasing crude impurity profiles and enhancing crude yields.
While 10mg lyophilized powder remains the gold standard for immediate reconstitution, future therapeutic applications focus on sustained-release microparticle technologies.
Encapsulating GHRP-2 inside biodegradable PLGA (Poly-lactic-co-glycolic acid) microspheres enables controlled release profiles spanning 14 to 30 days. This minimizes dose frequency, maintains constant therapeutic plasma levels, and reduces systemic peak-valley fluctuations.
Dedicated international liaison offices ensuring frictionless regulatory alignment across global markets.
With established operations and direct representatives in Mexico, Gentolex streamlines import documentation, COFEPRIS alignment, localized customs clearance, and dedicated customer support across Central and South America.
Our dedicated representative setup in South Africa provides robust logistical entry points into Southern Africa and EMEA markets, ensuring local currency settlement options, rapid local warehouse fulfillment, and regulatory dossier compliance.
All production processes strictly adhere to US FDA cGMP guidelines, EDQM requirements, and ISO 9001:2015 quality standards. Complete batch documentation permits seamless regulatory audits by global client teams.
Essential guidance for commercial procurement managers, formulation chemists, and institutional buyers.
Stay informed with the latest scientific developments and technical articles from our biopharmaceutical research division.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous...
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and life science entities globally...
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation...
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment...
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, stabilizing mitochondrial structure and supporting cellular bioenergetics...
Discover our extended portfolio of APIs, protected amino acids, and high-purity fine chemical solutions.
